Alosetron Hydrochloride is a 5-HT3 antagonist used only for the management of severe diarrhoea-predominant irritable bowel syndrome in women. It was patented in 1987 and approved for medical use in 2002. Reference standards of Alosetron Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Alosetron Hydrochloride
Catalogue No.:PA 28 22000
CAS :
Molecular Formula : C17H19ClN4O
Molecular Weight : 330.81
N-Desmethyl Alosetron
Catalogue No.:PA 28 22510
Molecular Formula : C16H16N4O
Molecular Weight : 280.32
6-Hydroxy Alosetron
Catalogue No.:PA 28 22520
Molecular Formula : C17H18N4O2
Molecular Weight : 310.35
7-Hydroxy Alosetron
Catalogue No.:PA 28 22530
1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indole
Catalogue No.:PA 28 22540
Molecular Formula : C15H20BNO2
Molecular Weight : 257.14
5-Methyl-2-(4-methyl-4,5-dihydro-1H-imidazole-5-carbonyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one
Catalogue No.:PA 28 22550
Molecular Weight : 310.36
Alosetron N-β-D-Glucuronide
Catalogue No.:PA 28 22560
Molecular Formula : C2326N4O7
Molecular Weight : 470.48
Alosetron M5
Catalogue No.:PA 28 22570
4-Hydroxy Alosetron
Catalogue No.:PA 28 22580
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
